Neuroscience of Psychedelics Workshop - Part 3/4

Franz X. Vollenweider presents neurobiological research on the mechanisms of psilocybin, ketamine, and MDMA. He outlines the history of hallucinogen research in Switzerland and introduces his team's clinical and neuroimaging methodology, which treats psychedelics as tools to modulate various aspects of consciousness. The research explores how these substances regulate emotional processing and sensory gating. By analyzing neural correlates such as ego-dissolution and perceptual alterations, the work bridges the gap between phenomenology and clinical application. Vollenweider highlights the importance of standardized models to map complex psychedelic states to measurable neurological changes.